Improvements in dialysis technology allow replacement therapy for even the youngest of children with end stage renal disease. Nevertheless, the cumulative experience in this age group is limited. Nephrology Dialysis Transplantation
Urotensin II, a cyclic vasoactive peptide expressed in multiple organs, had higher plasma levels to predict longer survival in dialysis patients. Does this association exist in earlier stages of CKD? Kidney International
There is a need to establish the level of nonadherence to phosphate binding medication in renal dialysis patients and identify the factors associated with it. BMC Nephrology
Patients on dialysis for ESRD have a high CV mortality that can only be partially explained by traditional risk factors. Outcomes in new HD patients treated with sevelamer or CBPBs are compared. Nephrology Dialysis Transplantation
calcification (VC) and arterial stiffness are major contributors to CV disease in CKD, but few studies have addressed the extent of VC in the pre-dialysis CKD population. Nephrology Dialysis Transplantation
